论文参麦川芎嗪注射液辅助治疗慢性肺源性心脏病的疗效观察是关于对写作肺源性心脏病论文范文与课题研究的大学硕士、相关本科毕业论文肺源性心脏病论文开题报告范文和相关文献综述及职称论文参考文献资料下载有帮助。
【摘 要】 目的 探讨参麦、川芎嗪注射液辅助治疗慢性肺源性心脏病（肺心病）的疗效.
方法 选择肺心病患者40例（治疗组）,在常规治疗的基础上加用参麦注射液及川芎嗪注射液治疗14天,并与40例常规治疗组（对照组）比较,观察治疗前后两组患者二氧化碳分压（PaCO2）、血氧分压（PaO2）和脑钠肽（BNP）的变化情况.
结果 治疗组治疗前PaCO2、PaO2、BNP水平分别为（73.99±5.63）mmHg、（51.12±4.60）mmHg和（3264.73±671.66）pg/ml,治疗后为（5841±6.02）mmHg、（63.71±3.53）mmHg和（241.25±80.58）pg/ml；对照组治疗前为（73.90±4.75）mmHg、（51.09±398）mmHg和（3205.72±713.18）pg/ml,治疗后为（63.29±4.72）mmHg、（57.95±3.68）mmHg和（470.56±156.65）pg/ml.两组PaCO2、BNP治疗前水平较高,治疗后水平下降（P<0.01）,PaO2治疗前水平较低,治疗后提高（P<0.01）,提示两组治疗均有效,治疗前两组的PaCO2、PaO2和BNP水平比较差异无统计学意义（P>0.05）,治疗后治疗组PaCO2、BNP水平较对照组低,PaO2水平较对照组高（P<0.01）,提示参麦注射液和川芎嗪注射液辅助治疗肺心病疗效优于常规治疗组.
结论 参麦注射液联合川芎嗪注射液辅助治疗肺心病可有效改善慢性肺源性心脏病患者血清PaCO2,PaO2和BNP水平,对改善患者心肺功能,提高临床疗效有益.
【关键词】 慢性肺源性心脏病肺；参麦注射液；川芎嗪注射液
中图分类号：R541.5 文献标识码：A DOI：10.3969/j.issn.10031383.2015.05.003
Observation of the effects of Shenmai injection and ligustrazine injection in the adjuvant treatment of chronic pulmonary heart disease
[HJ1*2][HJ]
ZHANG Qiang1,LIANG Xianfeng1,HUANG Yansu1,LI Jindu2,LI Tianzi3
（1.Department of Cardiovasology and Respiratory Medicine,People’s Hospital of Jingxi,Jingxi 533800；2.The Second Class of Grade 2012 in Longtermsystem,Guangxi Medical University,Nanning 530021；3.Affiliated Hospital of Youjiang Medical University for Nationalities,Baise 533000,Guangxi,China）
[HJ1*2][HJ]
【Abstract】 Objective To investigate the effects of Shenmai injection and ligustrazine injection in the adjuvant treatment of chronic pulmonary heart disease.
Methods 40 cases of pulmonary heart disease （treatment group） were treated with Shenmai injection and ligustrazine injection for 14 days on the basis of conventional treatment,and they were compared to 40 cases （control group） who were treated with conventional treatment only.The changes of partial pressure of carbon dioxide（PaCO2）,partial pressure of oxygen（PaO2） and brain natriuretic peptide （BNP） before and after treatment were observed in the two groups.
Results Before treatment,levels of PaCO2,PaO2 and BNP in the treatment group were（73.99±5.63）mmHg,（51.12±4.60）mmHg and（3264.73±671.66）pg/ml respectively,while those after treatment were （58.41±6.02）mmHg,（63.71±3.53） mmHg and （241.25±80.58） pg/ml respectively.Before treatment,levels of PaCO2,PaO2,BNP in the control group were （73.9±4.75） mmHg,（51.09±3.98）mmHg and （3205.72±713.18） pg/ml respectively,while those after treatment were （63.29±4.72）mmHg,（57.95±3.68）mmHg and （470.56±156.65） pg/ml respectively.Levels of PaCO2,BNP in both groups were relatively high before treatment,but they decreased after treatment （P<0.01）,PaO2 level was relatively low,but it increased after treatment（P<0.01）,which showed that both groups got positive effects in the treatment,and difference of PaCO2,PaO2 and BNP were not statistically significant before treatment in the two groups（P>0.05）.After treatment,the levels of PaCO2 and BNP in the treatment group were lower than those in the control group,while PaO2 level was higher than that of the control group（P<0.01）,which showed that Shenmai injection and ligustrazine injection had better effect than conventional treatment in the adjuvant treatment of chronic pulmonary disease.
总结:该文是关于肺源性心脏病论文范文，为你的论文写作提供相关论文资料参考。
参考文献：
1、 喜炎平辅助利巴韦林治疗普通型小儿手足口病的疗效观察 手足口病（hand-food-mouth disease，HFMD）是由多种肠道病毒感染引起的常见急性传染病，主要病原体为柯萨奇病毒A组16型（。
2、 悬吊运动疗法辅助治疗脊柱关节炎性腰背痛的临床观察 【摘 要】目的：观察悬吊运动疗法辅助治疗脊柱关节炎性腰背痛的临床疗效。方法：将74例脊柱关节炎性腰背痛患者随机分为治疗组和对照组，每组37例。对。
3、 曲美他嗪对改善糖尿病合并冠心病患者心功能不全疗效观察 [摘要] 目的 探讨曲美他嗪对改善糖尿病合并冠心病患者心功能不全的临床疗效。方法 选取2015年1月—2016年7月该院收治的86例糖尿病合并冠。
4、 糖脉康联合甲钴胺治疗糖尿病神经源性膀胱临床观察 [摘要] 目的 观察糖脉康联合甲钴胺对糖尿病神经源性膀胱患者的疗效。 方法 选择于该院住院治疗的60例糖尿病神经源性膀胱患者，随机分成对照组和治。
5、 丹参酮联合多西环素维A酸乳膏治疗脓疮性痤疮疗效观察 痤疮为常见的毛囊皮脂腺慢性炎症性疾病,尤其脓疮性痤疮，多发生于青年人,因多发生于颜面部,加上有些患者不科学的挤压造成永久性疤痕,影响容貌,给广大。
6、 王氏保赤丸治疗儿童功能性消化不良110例疗效观察 摘 要 目的：观察王氏保赤丸治疗儿童功能性消化不良的临床疗效。方法：将200例患儿随机分为2组，其中观察组110例，口服王氏保赤丸；对照组90例。